Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

프로바이오틱스에 의한 알레르기 질환 제어 및 안전성Control of Allergy with Probiotics and Its Safety

Other Titles
Control of Allergy with Probiotics and Its Safety
Authors
이예원윤요한
Issue Date
Mar-2020
Publisher
한국낙농식품응용생물학회
Keywords
probiotics; allergic diseases; atopic dermatitis; asthma; allergic rhinitis; food allergy
Citation
Journal of Dairy Science and Biotechnology, v.38, no.1, pp 19 - 26
Pages
8
Journal Title
Journal of Dairy Science and Biotechnology
Volume
38
Number
1
Start Page
19
End Page
26
URI
https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/1564
DOI
10.22424/jdsb.2020.38.1.19
ISSN
2733-4554
2733-4562
Abstract
Allergic diseases, including atopic dermatitis, asthma, allergic rhinitis, and food allergies, could be caused by dysbiosis that results in an immune system imbalance. The incidence of allergic diseases has been increasing and they are now one of the most common diseases throughout the world. Recently, probiotics have been suggested as an alternative intervention for the prevention and treatment of allergic diseases. Probiotics are endogenous microflora with functional effects within hosts. They have various clinical and immunological capacities and have recently been considered as a supplement for the treatment and prevention of allergic diseases. Probiotic bacteria modulate immune cells such as Th1, Th2, and regulatory T cells that are correlated with protection against atopic dermatitis, however, safety concerns for the use of probiotics have been raised. Therefore, further research is needed to clarify the efficacy and safety of probiotics in the treatment of allergic diseases.
Files in This Item
Go to Link
Appears in
Collections
생활과학대학 > 식품영양학과 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Yoon, Yo Han photo

Yoon, Yo Han
생활과학대학 (식품영양학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE